Expression and molecular profiles of the AlkB family in ovarian serous carcinoma

被引:4
|
作者
Cai, Yuan [1 ]
Wu, Geting [1 ]
Peng, Bi [1 ]
Li, Juanni [1 ]
Zeng, Shuangshuang [2 ]
Yan, Yuanliang [2 ]
Xu, Zhijie [1 ,3 ]
机构
[1] Cent South Univ, Xiangya Hosp, Dept Pathol, Changsha 410008, Hunan, Peoples R China
[2] Cent South Univ, Xiangya Hosp, Dept Pharm, Changsha 410008, Hunan, Peoples R China
[3] Cent South Univ, Xiangya Hosp, Natl Clin Res Ctr Geriatr Disorders, Changsha 410008, Hunan, Peoples R China
来源
AGING-US | 2021年 / 13卷 / 07期
基金
中国博士后科学基金; 中国国家自然科学基金;
关键词
ovarian serous carcinoma; AlkB family; expression profiles; infiltrating immune cells; methylation; CANCER PROGRESSION; M(6)A;
D O I
暂无
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
AlkB family of Fe (II) and alpha-ketoglutarate-dependent dioxygenases plays essential roles in development of ovarian serous carcinoma (OV). However, the molecular profiles of AlkB family in OV have not been clarified. The results indicated that the expression of ALKBH1/3/5/8 and FTO was lower in OV patients while ALKBH2/4/6/7 expression was higher. There was a strong correlation between ALKBH5/7 and pathological stage of OV patients. KaplanMeier plotter revealed that OV patients with high ALKBH4 level showed longer overall survival (OS). However, patients with high levels of ALKBH5/6 and FTO showed shorter OS and progression-free survival (PFS). Genetic alterations using cBioPortal revealed that the alteration rates of FTO were the highest. We also found that the functions of AlkB family were linked to several cancer-associated signaling pathways, including chemokine receptor signaling. TIMER database indicated that the AlkB family had a strong relationship with the infiltration of six types of immune cells (macrophages, neutrophils, CD8+ T-cells, B-cells, CD4+ T-cells and dendritic cells). Next, DiseaseMeth databases revealed that the global methylation levels of ALKBH1/2/3/4/5/6/7/8 and FTO were all lower in OV patients. Thus, our findings will enhance the understanding of AlkB family in OV pathology, and provide novel insights into AlkB-targeted therapy for OV patients.
引用
收藏
页码:9679 / 9692
页数:14
相关论文
共 50 条
  • [21] PRMT1 expression predicts sensitivity to platinum-based chemotherapy in patients with ovarian serous carcinoma
    Matsubara, Hiroaki
    Fukuda, Takeshi
    Awazu, Yuichiro
    Nanno, Shigenori
    Shimomura, Masahiro
    Inoue, Yuta
    Yamauchi, Makoto
    Yasui, Tomoyo
    Sumi, Toshiyuki
    ONCOLOGY LETTERS, 2021, 21 (02)
  • [22] Zinc Finger Protein 24 is a Prognostic Factor in Ovarian Serous Carcinoma
    Chen, Jia
    Guo, Juan
    Yuan, Yujuan
    Wang, Yadong
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2022, 30 (02) : 136 - 144
  • [23] Ovarian Serous Carcinoma: A Retrospective Study of Clinicopathological Findings and Postchemotherapy Changes
    Vangala, Navatha
    Uppin, Shantveer G.
    Uppin, Megha S.
    Paul, Tara Roshni
    Sadashivudu, G.
    INDIAN JOURNAL OF MEDICAL AND PAEDIATRIC ONCOLOGY, 2020, 41 (05) : 663 - 669
  • [24] Ovarian Serous Carcinoma With a Novel HSP90AB1 Mutation in a Patient With Synchronous Primary Fallopian Tube Serous Carcinoma
    Lai, Jinping
    Tong, Caili
    Chien, Jeremy R.
    ANTICANCER RESEARCH, 2021, 41 (09) : 4417 - 4422
  • [25] Clinicopathological significance and underlying molecular mechanism of downregulation of basonuclin 1 expression in ovarian carcinoma
    Liang, Zi-Qian
    Zhong, Lu-Yang
    Li, Jie
    Shen, Jin-Hai
    Tu, Xin-Yue
    Zhong, Zheng-Hong
    Zeng, Jing-Jing
    Chen, Jun-Hong
    Wei, Zhu-Xin
    Dang, Yi-Wu
    Huang, Su-Ning
    Chen, Gang
    EXPERIMENTAL BIOLOGY AND MEDICINE, 2022, 247 (02) : 106 - 119
  • [26] Lung Resistance-Related Protein (LRP) Expression in Malignant Ascitic Cells as a Prognostic Marker for Advanced Ovarian Serous Carcinoma
    Elizabeth H. Kerr
    Peter J. Frederick
    Michael E. Egger
    Cecil R. Stockard
    Jeffery Sellers
    Debbie DellaManna
    Denise K. Oelschlager
    Hope M. Amm
    Isam-Eldin Eltoum
    J. Michael Straughn
    Donald J. Buchsbaum
    William E. Grizzle
    Lacey R. McNally
    Annals of Surgical Oncology, 2013, 20 : 3059 - 3065
  • [27] Ovarian serous carcinoma with stomach metastasis: a rare case report and literature review
    Hu, Jia-Li
    Guo, Zhao-Jiao
    Wang, Chun
    Yan, Jun
    Yang, Hao
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2024, 52 (04)
  • [28] Virchow's node as a first manifestation of ovarian serous carcinoma: case report
    Cebesoy, F. B.
    Balat, O.
    Aydin, A.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2008, 29 (02) : 182 - 183
  • [29] Low-grade serous ovarian carcinoma is a rare histological subtype in Japan
    Iwahashi, Hideki
    Miyamoto, Morikazu
    Sakamoto, Takahiro
    Ishibashi, Hiroki
    Kakimoto, Soichiro
    Matsuura, Hiroko
    Tsuda, Hitoshi
    Takano, Masashi
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2020, 41 (06) : 1004 - 1009
  • [30] Profiles of Genomic Instability in High-Grade Serous Ovarian Cancer Predict Treatment Outcome
    Wang, Zhigang C.
    Birkbak, Nicolai Juul
    Culhane, Aedin C.
    Drapkin, Ronny
    Fatima, Aquila
    Tian, Ruiyang
    Schwede, Matthew
    Alsop, Kathryn
    Daniels, Kathryn E.
    Piao, Huiying
    Liu, Joyce
    Etemadmoghadam, Dariush
    Miron, Alexander
    Salvesen, Helga B.
    Mitchell, Gillian
    DeFazio, Anna
    Quackenbush, John
    Berkowitz, Ross S.
    Iglehart, J. Dirk
    Bowtell, David D. L.
    Matulonis, Ursula A.
    CLINICAL CANCER RESEARCH, 2012, 18 (20) : 5806 - 5815